Veracyte (VCYT): Assessing Whether Recent Momentum Justifies Its Current Valuation [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
See our latest analysis for Veracyte. With the share price recently at $42.39, Veracyte's 90 day share price return of 17.62% contrasts with a modest 1 year total shareholder return of 1.15%. This suggests momentum has picked up again after a softer stretch. If you like Veracyte's diagnostics angle but want more ideas in the space, now is a good time to explore other healthcare stocks that could fit your strategy. With revenue and earnings both growing double digits and the stock still trading at a notable intrinsic discount and below analyst targets, the key question now is whether Veracyte is a genuine opportunity to consider or if the market has already priced in its future growth. Based on the most popular narrative, Veracyte's implied fair value of about $47.50 sits above the last close at $42.39, framing the stock as modestly discounted while hinging on specific growth and margin assumptions. Analysts expect earnings to reach $121.9 million (and earnings per share of
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Veracyte (NASDAQ:VCYT) had its "buy" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results [Yahoo! Finance]Yahoo! Finance
- Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 ResultsBusiness Wire
- Veracyte (NASDAQ:VCYT) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
VCYT
Earnings
- 11/4/25 - Beat
VCYT
Sec Filings
- 1/12/26 - Form 8-K
- 1/8/26 - Form SCHEDULE
- 12/17/25 - Form 4
- VCYT's page on the SEC website